.jpg)
Lax Enforcement Spurs Suits Over Insurers' 'Ghost' Networks
More patients are alleging that what are known as insurers' ghost networks — directories full of unreachable providers — deny them access to mental health care. Their counsel say scarce enforcement is just one of the problems.
PE-Backed Medical Supplies Giant Medline Eyes $5B IPO
Private equity-backed medical supplies behemoth Medline has outlined terms for its long-awaited initial public offering, telling U.S. regulators that it plans to raise about $5 billion in what would mark the largest IPO of 2025.
Fed. Circ. Erases $41.8M Verdict Over Seagen Cancer Drug IP
The Federal Circuit in a precedential opinion Tuesday reversed a $41.8 million verdict against Daiichi Sankyo for infringing a Seagen breast cancer treatment patent, saying a lower court should have found that the patent didn't adequately describe the claimed invention or enable a skilled person to use it.
Lax Enforcement Spurs Suits Over Insurers' 'Ghost' Networks
More patients are alleging that what are known as insurers' ghost networks — directories full of unreachable providers — deny them access to mental health care. Their counsel say scarce enforcement is just one of the problems.
PE-Backed Medical Supplies Giant Medline Eyes $5B IPO
Private equity-backed medical supplies behemoth Medline has outlined terms for its long-awaited initial public offering, telling U.S. regulators that it plans to raise about $5 billion in what would mark the largest IPO of 2025.
Fed. Circ. Erases $41.8M Verdict Over Seagen Cancer Drug IP
The Federal Circuit in a precedential opinion Tuesday reversed a $41.8 million verdict against Daiichi Sankyo for infringing a Seagen breast cancer treatment patent, saying a lower court should have found that the patent didn't adequately describe the claimed invention or enable a skilled person to use it.
Expert Analysis
Two federal court decisions suggesting that the Internal Revenue Service's rules for 501(c)(4) organizations' poli... (more story)
On Dec. 12, the Eleventh Circuit will hear arguments in U.S. ex rel. Zafirov v. Florida Medical Associates, settin... (more story)
The national spotlight on the federal government's Make America Healthy Again movement is bolstering state-level a... (more story)
Deals & Corporate Governance More
Executives and directors of health insurance provider Molina Healthcare were hit with a shareholder's derivative suit Friday accusing them of misleading investors about medical cost trends and internal control... (more story)
A Maryland federal judge signed off on the U.S. Department of Justice settlement resolving its challenge to UnitedHealth's $3.3 billion acquisition of home health and hospice company Amedisys, under a deal req... (more story)
Insurer Elevance Health has appointed former Pfizer Inc. general counsel Amy Schulman, currently a managing partner of Polaris Partners, to serve on its board of directors.
Private equity-backed diagnostic imaging provider Lumexa Imaging Holdings Inc., led by Sidley Austin LLP, began trading Thursday on the Nasdaq Global Select Market after pricing a $463 million initial public offering.
Perimeter Solutions Inc. has agreed to acquire Medical Manufacturing Technologies LLC from Arcline Investment Management for approximately $685 million in cash, including certain tax benefits.
A California federal judge has granted preliminary approval to a deal ending shareholder derivative claims that diagnostics company CareDx's executives and directors damaged the company by concealing its schem... (more story)
Digital Health & Technology More
Texas Attorney General Ken Paxton hit Epic Systems Corp. with an antitrust suit in state court on Wednesday alleging the company is illegally seeking to monopolize markets for electronic health records software.
An Illinois state appeals court affirmed the dismissal of a man's suit claiming two State Farm life insurers violated Illinois' genetic information privacy law, finding a section barring the use of genetic pro... (more story)
Over 1.6 million patients affected by HealthEC's cybersecurity attack in 2023 asked a New Jersey magistrate judge for her final stamp of approval on a $5.48 million class action settlement, arguing Monday the ... (more story)
Apple Inc. has told the Federal Circuit that the U.S. International Trade Commission's decision last month to review whether a redesigned Apple Watch infringes Masimo Corp. patents "underscores the need" for t... (more story)
A trio of Dechert LLP partners, including the co-chair of its global intellectual property practice, have joined Cooley LLP alongside a team of special counsel, associates and patent agents, the firm announced Tuesday.
A Georgia-based medical billing practice asked a federal judge to dismiss a proposed class action accusing it of failing to properly secure its patients and employees' personal information that was exposed in ... (more story)
Policy & Compliance More
It was premature for a trial court to find that a liability statute protected a Bronx-based nursing home from a suit over a patient's death, a New York appellate court ruled Thursday, concluding further fact i... (more story)
An Ohio federal judge refused Friday to toss a proposed class action from two Sherwin Williams ex-workers who alleged an employee health plan tobacco surcharge violated nondiscrimination provisions in federal ... (more story)
The Eleventh Circuit Friday weighed both the history of whistleblower laws going back to the nation's founding and recent U.S. Supreme Court commentary on qui tam litigation in a closely watched challenge to t... (more story)
A group of transgender youths and their families urged Ohio's highest court to affirm their win overturning state restrictions on gender-affirming care, arguing undisputed evidence at trial backed their argume... (more story)
A Sixth Circuit appeals panel gave few hints Thursday on whether it would send back to state court a lawsuit from Ohio alleging that pharmacy benefit managers were driving up prescription prices through rebate schemes.
The states of Florida and Texas again took aim at the U.S. Food and Drug Administration's approval of abortion medication mifepristone, saying in a Tuesday suit that the agency flouted federal law in greenligh... (more story)